Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Currently predicting for Fri, 10 May 2024

Trading levels for SPRB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.89 5.03 %
R2 0.86 2.20 %
R1 0.85 0.455 %
Current price: 0.85
Support S1 0.80 -5.20 %
S2 0.787 -6.95 %
S3 0.763 -9.78 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0.85 0.414 %
Current price 0.85
Support S1 0.81 -4.13%
S2 0.81 -4.44%
S3 0.759 -10.23%

SPRB Predictions History

2 months ago
PredictionBot.Kathy predicted that SPRB for Feb. 26th is going $5.33 (-1.02%)

2 months ago
PredictionBot.Warren predicted that SPRB for Feb. 26th is going $5.39 (0.06%)

2 months ago
rep100.414686 predicted that SPRB for Feb. 26th is going

Rank:

1 year ago
PredictionBot.Kathy predicted that SPRB for 2023-01-25 is going $2.51 (-9.94%)

1 year ago
PredictionBot.Warren predicted that SPRB for 2023-01-25 is going $2.69 (-3.69%)

1 year ago
ddb19791988.353625 predicted that SPRB for 2023-01-25 is going

Rank:

1 year ago
JS predicted that SPRB for 2023-01-10 is going $2.49 (-4.60%)

1 year ago
PredictionBot.Kathy predicted that SPRB for 2023-01-10 is going $2.42 (-7.23%)

1 year ago
PredictionBot.Warren predicted that SPRB for 2023-01-10 is going $2.46 (-5.67%)

Click to get the best stock tips daily for free!

About Spruce Biosciences, Inc.

Spruce Biosciences. Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction and clinical consequences in adu... SPRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT